OKYO Pharma Ltd. operates as a biopharmaceutical company, which engages in the development of therapeutics for inflammatory eye diseases and chronic pain. It operates through the US and UK geographical segments. The company was founded on July 4, 2007 and is headquartered in London, the United Kingdom.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of OKYO Pharma Limited - Ordinary Shares - New?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. OKYO Pharma Limited - Ordinary Shares - New market cap is $80.11M.
What is the 52-week high for OKYO Pharma Limited - Ordinary Shares - New?
52 week high is the highest price of a stock in the past 52 weeks, or one year. OKYO Pharma Limited - Ordinary Shares - New 52 week high is $3.35 as of September 18, 2025.
What is the 52-week low for OKYO Pharma Limited - Ordinary Shares - New?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OKYO Pharma Limited - Ordinary Shares - New 52 week low is $0.9016 as of September 18, 2025.
What is OKYO Pharma Limited - Ordinary Shares - New stock price today?
OKYO Pharma Limited - Ordinary Shares - New stock price today is $2.11.
What was OKYO Pharma Limited - Ordinary Shares - New stock price yesterday?
OKYO Pharma Limited - Ordinary Shares - New stock price yesterday was $2.13.
What is the PE ratio of OKYO Pharma Limited - Ordinary Shares - New?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. OKYO Pharma Limited - Ordinary Shares - New’s P/E ratio is -15.65.
What is the Price-to-Book ratio of OKYO Pharma Limited - Ordinary Shares - New?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. OKYO Pharma Limited - Ordinary Shares - New P/B ratio is -13.8249.
What is the 50-day moving average of OKYO Pharma Limited - Ordinary Shares - New?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. OKYO Pharma Limited - Ordinary Shares - New 50-day moving average is $2.60.
